XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.2
Background (Details)
6 Months Ended
Aug. 05, 2025
Jun. 22, 2025
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
employee
$ / shares
Aug. 01, 2025
USD ($)
Dec. 31, 2024
$ / shares
Background          
Common stock, par value (in USD per share) | $ / shares     $ 0.001   $ 0.001
Combined Company          
Background          
Ownership (as a percent)   90.00%      
Subsidiary, ownership, noncontrolling owner (as a percent)   10.00%      
Combined Company          
Background          
Net cash as of closing   $ 0      
Valuation amount   15,000,000      
Exchange ratio, minimum net cash available   0      
Termination fee   $ 500,000      
Subsequent Event | Private Placement | Ocugen          
Background          
Subscription agreement       $ 5,000,000  
Minimum | Subsequent Event          
Background          
Conversion ratio 0.10        
Maximum | Subsequent Event          
Background          
Conversion ratio 0.02        
OrthoCellix Inc          
Background          
Common stock, par value (in USD per share) | $ / shares   $ 0.00001      
OrthoCellix Inc | Combined Company          
Background          
Concurrent investment   $ 25,000,000      
Valuation amount   135,000,000      
Termination fee   750,000      
Reimbursement owed upon termination (up to)   $ 500,000      
Employee Severance | Cash Preservation Plan, 2025          
Background          
Reduction in workforce, number of employees | employee     37    
Reduction in workforce (as a percent)     84.00%    
Restructuring charges     $ 4,200,000